Theratechnologies Announces New Positive Results for two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer
Theratechnologies Inc. - Common Shares (THTX)
Company Research
Source: GlobeNewswire
TH1902 and TH1904 more effective and safer in vivo compared to current standard ovarian cancer treatments New data presented during the AACR Virtual Annual Meeting MONTREAL, April 27, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that new positive results about its two investigational peptide-drug conjugates (PDC) TH1902 and TH1904 will be presented tomorrow during an oral presentation at a virtual session of the Annual Meeting of the American Association for Cancer Research (AACR). Data from the oral presentation “Increasing potency of anticancer drugs through Sortilin receptor-mediated cancer therapy: A new targeted approach for the treatment of ovarian cancer,” show that both TH1902 (docetaxel peptide conjugate) and TH1904 (doxorubicin peptide conjugate), two unique Sortilin positive (SORT1+) targeting investigational PDCs, are more effective and better tolerate
Show less
Read more
Impact Snapshot
Event Time:
THTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
THTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
THTX alerts
High impacting Theratechnologies Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
THTX
News
- Theratechnologies Announces Completion of Acquisition by Future Pak [Canadian Business Journal (Canada)]Canadian Business Journal
- Theratechnologies Announces Completion of Acquisition by Future PakGlobeNewswire
- TruTechnologies Appoints Mirador Therapeutics Executive Jordan Zwick to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak [Canadian Business Journal (Canada)]Canadian Business Journal
- Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future PakGlobeNewswire
THTX
Sec Filings
- 9/25/25 - Form 25-NSE
- 9/25/25 - Form 6-K
- 9/17/25 - Form 6-K
- THTX's page on the SEC website